首页> 外国专利> A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PROPHYLAXIS OF DEMENTIA COMPRISING A GINSENOSIDE-F2 AND A GINSENOSIDE-CK

A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PROPHYLAXIS OF DEMENTIA COMPRISING A GINSENOSIDE-F2 AND A GINSENOSIDE-CK

机译:一种包含人参皂苷-F2和人参皂苷-CK的老年痴呆症的治疗和预防药物的药物组合物

摘要

A pharmaceutical composition for preventing and treating dementia, which contains a ginsenoside-F2(F2) and ginsenoside-CK as a main ingredient is provided to treat mild congnitive impairment and prevent degenerative brain diseases (Alzheimer disease, parkinson's disease, etc.). A pharmaceutical composition for preventing and treating dementia comprises a ginsenoside-F2 of the chemical formula 1 and ginsenoside-CK of the chemical formula 2 as main ingredient. In the chemical formulas 1 and 2, Glc indicates glucose. The content ratio of ginsenoside-F1 and ginsenoside-CK is 1:0.01~2. The content of the ginsenoside F2 and CK is 0.1~50 weight% based on the total weight. The amount of the composition in a health functional food is 0.01-15 weight% based on the total food weight.
机译:包含人参皂苷-F2(F2)和人参皂苷-CK作为主要成分的预防和治疗痴呆的药物组合物被提供用于治疗轻度的认知障碍和预防退行性脑疾病(阿尔茨海默氏病,帕金森氏病等)。预防和治疗痴呆的药物组合物包含化学式1的人参皂苷-F2和化学式2的人参皂苷-CK作为主要成分。在化学式1和2中,Glc表示葡萄糖。人参皂苷-F1和人参皂苷-CK的含量比为1:0.01〜2。人参皂苷F2和CK的含量为总重量的0.1〜50重量%。保健功能食品中组合物的量为食品总重量的0.01-15重量%。

著录项

  • 公开/公告号KR20090083780A

    专利类型

  • 公开/公告日2009-08-04

    原文格式PDF

  • 申请/专利权人 EUBIOSLAB CO. LTD.;

    申请/专利号KR20080009776

  • 发明设计人 HA NA YOUNG;KIM SANG WON;PARK JIN KYU;

    申请日2008-01-30

  • 分类号A61K31/704;A61K31/70;A61P25/28;

  • 国家 KR

  • 入库时间 2022-08-21 19:12:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号